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1. CASE REPORT {#ccr31955-sec-0001}
==============

Cutaneous Squamous Cell Carcinoma (SCC) is the second most common form of skin cancer, and the incidence is rising.[1](#ccr31955-bib-0001){ref-type="ref"} While some cutaneous SCC can be relatively indolent, with low‐risk malignant potential, they account for the majority of keratinocyte related metastases and death. A wide diversity of SCC variants exists, some of which are associated with more aggressive behavior.[2](#ccr31955-bib-0002){ref-type="ref"}

Osteoclast‐like giant cell (OLGC) proliferation has recently been described in cutaneous malignancies. The distinctive stromal changes containing OLGC were first described in 1967 and since have been reported in numerous malignant tumors of breast, liver, renal, uterus and more recently, skin. Since 2007, only 10 cases of SCC with OLGC have been reported. To date, the majority have been described in male elderly patients, occurring on sun‐exposed skin. High‐risk features such as moderate‐to‐poor differentiation, greater tumor size, recurrence and metastatic spread have been described.[3](#ccr31955-bib-0003){ref-type="ref"} We aim to present the 11th case reported to our knowledge of cutaneous SCC with OLGCs, with the objective to promote awareness of this rare SCC variant.

An 88‐year‐old man presented with an asymptomatic nodule on the temple which had grown rapidly over several weeks. He had a past history of SCC and basal cell carcinoma. There was no past history of melanoma or immunosuppression. On examination, an erythematous, hyperkeratotic nodule had grown over the left temple with a background of chronic sun‐damaged skin. No locoregional lymphadenopathy was detected. The lesion was clinically suspicious for SCC and complete excision was performed for histopathologic examination.

Histopathological examination revealed an invasive, poorly differentiated carcinoma measuring 3.0 mm in thickness extending to subcutis (Figure [1](#ccr31955-fig-0001){ref-type="fig"}A). Atypical cells were spindled and slightly ovoid with prominent nucleoli and plentiful OLGC within the carcinoma (Figure [1](#ccr31955-fig-0001){ref-type="fig"}B). No perineural or lymphovascular invasion was evident. Immunohistochemical staining of the spindled cells was positive for P63 and P40 indicating squamous cell origin (Figure [1](#ccr31955-fig-0001){ref-type="fig"}C,D). Multi‐nucleated cells stained positive for mesenchymal marker CD68 (Figure [1](#ccr31955-fig-0001){ref-type="fig"}E), and negative for giant cell tumor marker of bone (anti‐histone H3.3G34W rabbit monoclonal antibody) (Figure [1](#ccr31955-fig-0001){ref-type="fig"}F). P63 and P40 showed no immunoreactivity of OLGCs. The cytomorphology and immunohistochemistry staining was characteristic and consistent with poorly differentiated SCC with OLGC.

![A, H&E showing poorly differentiated carcinoma and giant cells invading into dermis and subcutis; B, Atypical spindled, ovoid cells with prominent nucleoli and plentiful OLGC; C, P40 immunoreactivity of spindle cells suggesting squamous origin; D, P63 staining spindle cells, lack of staining of giant cells; E, Giant cells staining CD68 suggestive of histiocyte differentiation; F, Lack of H3.3G34W giant cell uptake](CCR3-7-340-g001){#ccr31955-fig-0001}

OLGC resembles osteoclasts morphologically and immunohistochemically, but it has been unclear whether they possess the functional capabilities of true osteoclasts. The exact etiology of OLGC has been a source of controversy in both cutaneous and visceral malignancies. Proposed origins of OLGC have included neoplastic epithelial cells, neoplastic mesenchymal cells, and reactive mesenchymal cells.[3](#ccr31955-bib-0003){ref-type="ref"}, [4](#ccr31955-bib-0004){ref-type="ref"} In the current case, CD68 positivity was suggestive of mesenchymal origin, and lack of H3.3G34W tumor marker, a highly sensitive and specific marker,[5](#ccr31955-bib-0005){ref-type="ref"} supports the hypothesis that OLGC are benign, reactive histiocytes generated by the fusion of adjacent macrophages, (as opposed to neoplastic) histiocytes.

On review of the literature, the majority of SCC with OLGC have been reported in older (mean 79.6 years), and predominantly male (2:7.1) patients. The current case confirms the following characteristic features as described in the literature: sun damage, head and neck distribution, and rapid progression. Furthermore, the majority of cases have reported high‐risk features including moderate‐to‐poor differentiation and tumor size \>2 cm.[4](#ccr31955-bib-0004){ref-type="ref"}, [6](#ccr31955-bib-0006){ref-type="ref"} A review by Chung et al[3](#ccr31955-bib-0003){ref-type="ref"} reported 33% recurrence and nodal metastases in 17% of SCC with OLGC cases. This rare subtype of SCC appears to present with high‐risk SCC features. Some studies reported nodal metastasis in only 3.7% of cutaneous SCC.[7](#ccr31955-bib-0007){ref-type="ref"} OLGC infiltration appears to exert more invasive and prometastatic phenotypes. The exact cause for this is unknown. However, tumor osteoclastic cells in vivo have been found to actively promote tumor growth and lymphangiogenesis by secreting VEGF‐C.[8](#ccr31955-bib-0008){ref-type="ref"}

In summary, knowledge regarding the differential diagnosis and proper classification of these tumors is of great importance. Diagnosis of SCC with OLGC may pose challenges, due to its often high‐grade and poor differentiation. Clinicians and pathologists should be aware of this rare SCC variant to avoid misdiagnosis of a morphologically similar entity, as the malignant potential and prognosis of cutaneous SCC with OLGC may vary.
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